Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
17.09
-0.09 (-0.52%)
Nov 18, 2026, 1:33 PM EST - Market open
Immunome Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Immunome stock has a consensus rating of "Strong Buy" and an average price target of $35.13. The average 1-year stock price forecast is 105.56% higher than the current stock price, while the lowest is $23 (+34.58%) and the highest is $40 (+134.06%).
Price Target: $35.13 (+105.56%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Immunome stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 12 | 13 | 13 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 16 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Maintains $37 | Buy | Maintains | $37 | +116.50% | Nov 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $33 → $30 | Buy | Reiterates | $33 → $30 | +75.54% | Nov 10, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Reiterates $24 → $23 | Hold | Reiterates | $24 → $23 | +34.58% | Nov 10, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $40 | Buy | Maintains | $40 | +134.06% | Nov 10, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $35 | Buy | Maintains | $35 | +104.80% | Nov 10, 2026 |
Financial Forecast
Revenue This Year
n/a
from 6.94M
Decreased by -100.00%
Revenue Next Year
51.33M
EPS This Year
-2.46
from -2.43
EPS Next Year
-2.55
from -2.46
EPS and Forward PE are based on non-GAAP adjusted numbers.